Nihon Kohden (OTCMKTS:NHNKY) Posts Quarterly Earnings Results, Misses Expectations By $0.09 EPS

Nihon Kohden (OTCMKTS:NHNKY) posted its earnings results on Thursday. The company reported ($0.03) EPS for the quarter, missing the consensus estimate of $0.06 by ($0.09), Zacks reports. Nihon Kohden had a return on equity of 9.46% and a net margin of 6.08%.

Nihon Kohden Trading Down 2.9%

Shares of NHNKY stock traded down $0.28 during trading on Thursday, hitting $9.33. The company’s stock had a trading volume of 3,933 shares, compared to its average volume of 27,565. The business has a fifty day moving average of $9.11 and a 200-day moving average of $9.78. Nihon Kohden has a 52 week low of $8.12 and a 52 week high of $14.21. The company has a market cap of $1.57 billion, a PE ratio of 15.82 and a beta of 0.37.

Analyst Upgrades and Downgrades

Separately, Zacks Research raised shares of Nihon Kohden to a “hold” rating in a research report on Monday, April 27th. One analyst has rated the stock with a Strong Buy rating and one has issued a Hold rating to the stock. Based on data from MarketBeat, Nihon Kohden has an average rating of “Buy”.

About Nihon Kohden

Nihon Kohden Corporation is a Tokyo-based manufacturer of medical electronic equipment, founded in 1951. The company has built a reputation for innovation in patient monitoring and diagnostic systems, developing one of Japan’s earliest electrocardiogram (ECG) machines and pioneering transistor-based oscilloscopes for clinical use. Over the decades, Nihon Kohden has expanded its product portfolio to address a wide range of healthcare needs, from emergency response to intensive care and neurology.

The company’s core offerings include patient monitors, ECG and electroencephalograph (EEG) devices, defibrillators, infusion pumps, and neuromonitoring systems.